SCHEMBL2901647

SCHEMBL2901647

CCCC[S+]([O-])Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1616141 0.91
SCHEMBL30701397 0.88 TSHR (0.44)
SCHEMBL27033085 0.88 TSHR (0.44)
SCHEMBL29074323 0.88 TSHR (0.44)
SCHEMBL9248456 0.88
SCHEMBL6364555 0.88 TSHR (0.44)
SCHEMBL2645410 0.80
SCHEMBL8814930 0.79
Hexane SCHEMBL7134957 0.76 TSHR (0.50)
SCHEMBL19146515 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754591-B HDAC, JAK and BET three-target inhibitor and preparation method and application thereof 山东大学 2024-01-05 CN claimed
CN-113754591-B HDAC, JAK and BET three-target inhibitor and preparation method and application thereof 山东大学 2024-01-05 CN disclosed
CN-113929605-B Ortho-sulfonylated arylamine compound and synthesis method thereof 山东大学 2022-07-29 CN disclosed
CN-108409615-B Method for synthesizing enantiopure tert-butyl sulfenamide 大连双硼医药化工有限公司 2020-09-11 CN disclosed
CN-108467353-B Preparation method of enantiopure tert-butyl sulfinamide 大连双硼医药化工有限公司 2020-09-11 CN disclosed
CN-108558715-B Method for preparing enantiopure tert-butyl sulfenamide 上海平创化工科技有限公司 2020-08-07 CN disclosed
CN-110050331-A thermal atomic layer etching process ASM IP 控股有限公司 2019-07-23 CN disclosed
CN-109843866-A YAP1 inhibitors targeting YAP1 interaction with OCT4 H·李·莫菲特癌症中心研究有限公司 2019-06-04 CN disclosed
CN-107459532-B A kind of new Anti-cancer medicament intermediate 重庆南松凯博生物制药有限公司 2019-05-28 CN disclosed
CN-106478607-B Substituted heteroaryl compound and combinations thereof and purposes 广东东阳光药业有限公司 2019-05-24 CN disclosed
US-6573278-B2 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma BAYER AKTIENGESELLSCHAFT (DE) 2003-06-03 US disclosed
EP-0966436-B1 ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES BAYER AG (DE) 2002-12-11 EP disclosed
US-20020072529-A1 Arylsulfonamides and analogues BAYER INTELLECTUAL PROPERTY GMBH (DE) 2002-06-13 US disclosed
US-6262112-B1 1-(4,4,4-TRIFLUOROBUTYLSULPHONYLOXY)-3-(2-(HYDROXYMETHYL)INDAN -4-YLOXY)-BENZENE BAYER AKTIENGESELLSCHAFT (DE) 2001-07-17 US disclosed
US-5574131-A REACTED WITH AN ACYL HALIDE, SOLUBILITY TOMOEGAWA PAPER CO., LTD. (JP) 1996-11-12 US disclosed
EP-0455224-B1 Polyaniline derivatives and their production process TOMOEGAWA PAPER CO LTD (JP) 1996-08-14 EP disclosed
US-5254670-A Polyaniline derivatives and their production process TOMOEGAWA PAPER CO., LTD. (JP) 1993-10-19 US disclosed
EP-0455224-A2 Polyaniline derivatives and their production process TOMOEGAWA PAPER CO. LTD. (JP) 1991-11-06 EP disclosed
US-4584371-A Catalytic process for preparing 3-ester-methyl cephalosporins from desacetyl-7-aminocephalosporanic acid THE UPJOHN COMPANY (US) 1986-04-22 US disclosed
EP-0153874-A2 Cephalosporin intermediates and their preparation THE UPJOHN COMPANY (US) 1985-09-04 EP disclosed